Alnylam Pharmaceuticals, Inc. (ALNY)
333.00
+10.89
(+3.38%)
USD |
NASDAQ |
Apr 13, 16:00
333.11
+0.11
(+0.03%)
After-Hours: 20:00
Alnylam Pharmaceuticals Cash from Investing (TTM) : 436.33M for Dec. 31, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| Pfizer Inc. | -1.351B |
| Eli Lilly & Co. | -10.97B |
| Ionis Pharmaceuticals, Inc. | -277.78M |
| Regeneron Pharmaceuticals, Inc. | -629.10M |
| Sarepta Therapeutics, Inc. | 69.64M |